Relmada Therapeutics, Inc.
RLMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$80 | -$99 | -$157 | -$126 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $30 | $0 | $44 | $40 |
| Change in WC | -$2 | $3 | $11 | -$8 |
| Other Non-Cash | -$0 | $44 | -$2 | $1 |
| Operating Cash Flow | -$52 | -$52 | -$104 | -$92 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$12 | -$90 | -$47 | -$223 |
| Inv. Sales/Matur. | $64 | $141 | $67 | $169 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $52 | $50 | $20 | -$54 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $43 | $185 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | $2 | $3 |
| Financing Cash Flow | -$0 | -$0 | $45 | $188 |
| Forex Effect | $0 | -$0 | $0 | $0 |
| Net Chg. in Cash | -$0 | -$1 | -$39 | $42 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4 | $5 | $44 | $2 |
| End Cash | $4 | $4 | $5 | $44 |
| Free Cash Flow | -$52 | -$52 | -$104 | -$92 |